Bridger Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-66,300	Closed	-$767K	–	48
2022 Q2	$767K	Buy	+66,300	New	+$767K	0.17%	39